Geron
GERN
#6702
Rank
โ‚น80.13 B
Marketcap
โ‚น124.73
Share price
-0.76%
Change (1 day)
11.75%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -โ‚น3.16 Billion

According to Geron's latest financial reports the company's current earnings are โ‚น0.19 Billion. In 2025 the company made an earning of -โ‚น4.88 Billion, an increase over its 2024 earnings that were of -โ‚น14.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น3.16 Billion-35.4%
2025 -โ‚น4.88 Billion-67.42%
2024 -โ‚น14.98 Billion-11.23%
2023 -โ‚น16.87 Billion30.22%
2022 -โ‚น12.96 Billion20.15%
2021 -โ‚น10.79 Billion50.08%
2020 -โ‚น7.19 Billion4.46%
2019 -โ‚น6.88 Billion130.68%
2018 -โ‚น2.99 Billion8.84%
2017 -โ‚น2.74 Billion-3.08%
2016 -โ‚น2.83 Billion-22080.6%
2015 โ‚น12.85 M-100.38%
2014 -โ‚น3.42 Billion-7.14%
2013 -โ‚น3.68 Billion
2011 -โ‚น8.7 Billion19.04%
2010 -โ‚น7.31 Billion8.45%
2009 -โ‚น6.74 Billion-2.51%
2008 -โ‚น6.92 Billion14.65%
2007 -โ‚น6.03 Billion32.68%
2006 -โ‚น4.55 Billion25.59%
2005 -โ‚น3.62 Billion4.36%
2004 -โ‚น3.47 Billion19.73%
2003 -โ‚น2.9 Billion-15.46%
2002 -โ‚น3.43 Billion1.94%
2001 -โ‚น3.36 Billion33.59%
2000 -โ‚น2.52 Billion27.53%
1999 -โ‚น1.98 Billion63.13%
1998 -โ‚น1.21 Billion15.6%
1997 -โ‚น1.05 Billion-10.66%
1996 -โ‚น1.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚น1.029 T-30,147.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น170.19 B-5,068.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น6.65 Billion 93.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น15.04 B-539.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1.44 Billion-58.22%๐Ÿ‡บ๐Ÿ‡ธ USA